|Articles|January 1, 2013
- BioPharm International-01-01-2013
- Volume 26
- Issue 1
BioPharm International, January 2013 Issue (PDF)
The Future of BioPharma Innovation
Advertisement
Articles in this issue
about 13 years ago
Accelerating Change Marks 2012 for Life Sciencesabout 13 years ago
A Look Ahead at BioPharma Manufacturing and Regulationabout 13 years ago
Epigenetics Drives Pharma Innovationabout 13 years ago
A Look Ahead in Biomanufacturingabout 13 years ago
Drug Quality at Center Stage for FDA and Manufacturersabout 13 years ago
Falsified Medicines Directive Takes Shape in Europeabout 13 years ago
The Future of Biopharmaabout 13 years ago
Report from Brazilabout 13 years ago
Aseptic Processing: A Primerabout 13 years ago
Biologics: What Does the Future Hold?Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
Why AI-Native Cell Manufacturing Is the Future of Drug Discovery (Part 1)
3
Transforming Cell Therapy with Precise Human Biology Replication (Part 2)
4
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
5